Sources of Innovation in Gene Therapies — Approaches to Achieving Affordable Prices
Kerstin Noëlle Vokinger, Jerry Avorn, Aaron S. Kesselheim
Abstract
Prices charged for gene therapies are exceptionally high, even though the key innovations supporting their development have been heavily driven by academic and other research institutions.
Topics & Concepts
Key (lock)BusinessComputer scienceComputer securityCAR-T cell therapy researchCRISPR and Genetic EngineeringBiomedical Ethics and Regulation